Case study
Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research Findings
This executive summary details the key findings from the 5-dose MCV research in Zambia: improved coverage, reduced wastage, no cold chain constraints, and healthcare workers were more willing to open a 5-dose vial.
Authors
Languages
- English
Publication year
2019
Publisher
Dose Per Container Partnership
Type
Case study
Categories
- Vaccines & delivery devices
Diseases
- Measles
Countries
- Zambia
Organisations
- Bill & Melinda Gates Foundation (BMGF)
Tags
- Coverage monitoring
- Delivery device
- Planning, budgeting and financing
- Refrigerator / freezer
- Wastage
WHO Regions
- African Region
Topic references
DPCP-CASE-STUDIES
PORTFOLIO-LESSONS
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| A Switch for Sustainability in Ghana's Rotavirus Vaccine Program | Professor George Armah | 2020 | Case study | English |
| Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research Findings | Dose Per Container Partnership | 2019 | Case study | English |
| The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia | Ali Karim, Barbara Knittel, Frances Mwansa, Guissimon Phiri, Kirstin Krudwig, Natasha Kanagat, Robert Steinglass, Wendy Prosser | 2020 | Journal article | English |
